Labetalol Hcl 51662-1602-01
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 29, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA075303
Need to source Labetalol Hcl? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Labetalol Hydrochloride | 5 mg/mL |
Drug Class
Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Selected Package
51662-1602-01Selected1 VIAL in 1 BOX, UNIT-DOSE (51662-1602-1) / 20 mL in 1 VIAL
Other packages for this product(1)
20 mL in 1 VIAL (51662-1602-9)